1. Home
  2. PRTA vs GETY Comparison

PRTA vs GETY Comparison

Compare PRTA & GETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • GETY
  • Stock Information
  • Founded
  • PRTA 2012
  • GETY 1995
  • Country
  • PRTA Ireland
  • GETY United States
  • Employees
  • PRTA N/A
  • GETY N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • GETY Industrial Machinery/Components
  • Sector
  • PRTA Health Care
  • GETY Industrials
  • Exchange
  • PRTA Nasdaq
  • GETY Nasdaq
  • Market Cap
  • PRTA 809.8M
  • GETY 723.5M
  • IPO Year
  • PRTA N/A
  • GETY N/A
  • Fundamental
  • Price
  • PRTA $5.80
  • GETY $1.81
  • Analyst Decision
  • PRTA Buy
  • GETY Hold
  • Analyst Count
  • PRTA 9
  • GETY 5
  • Target Price
  • PRTA $27.67
  • GETY $4.35
  • AVG Volume (30 Days)
  • PRTA 2.4M
  • GETY 887.6K
  • Earning Date
  • PRTA 08-07-2025
  • GETY 08-08-2025
  • Dividend Yield
  • PRTA N/A
  • GETY N/A
  • EPS Growth
  • PRTA N/A
  • GETY N/A
  • EPS
  • PRTA N/A
  • GETY N/A
  • Revenue
  • PRTA $137,935,000.00
  • GETY $941,086,000.00
  • Revenue This Year
  • PRTA N/A
  • GETY $2.71
  • Revenue Next Year
  • PRTA $30.93
  • GETY $2.74
  • P/E Ratio
  • PRTA N/A
  • GETY N/A
  • Revenue Growth
  • PRTA 54.55
  • GETY 4.20
  • 52 Week Low
  • PRTA $4.32
  • GETY $1.25
  • 52 Week High
  • PRTA $25.42
  • GETY $4.49
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 46.16
  • GETY 51.55
  • Support Level
  • PRTA $4.95
  • GETY $1.72
  • Resistance Level
  • PRTA $6.00
  • GETY $2.09
  • Average True Range (ATR)
  • PRTA 0.32
  • GETY 0.10
  • MACD
  • PRTA 0.25
  • GETY 0.01
  • Stochastic Oscillator
  • PRTA 88.59
  • GETY 41.84

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About GETY Getty Images Holdings Inc.

Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.

Share on Social Networks: